Long-Term Results of Pulmonary Vein Isolation Plus Modified Posterior Wall Debulking Utilizing High-Power Short-Duration Strategy: An All-Comers Study in Real World.

Autor: Candemir B; Department of Cardiology, Faculty of Medicine, Ankara University, Ankara, Turkey., Baskovski E; Department of Cardiology, Faculty of Medicine, Ankara University, Ankara, Turkey., Beton O; Department of Cardiology, Faculty of Medicine, Cyprus International University, Nicosia, Turkish Republic of Northern Cyprus., Kozluca V; Department of Cardiology, Faculty of Medicine, Ankara University, Ankara, Turkey., Tan TS; Department of Cardiology, Faculty of Medicine, Ankara University, Ankara, Turkey., Altın T; Department of Cardiology, Faculty of Medicine, Ankara University, Ankara, Turkey., Tutar E; Department of Cardiology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Anatolian journal of cardiology [Anatol J Cardiol] 2022 Jun; Vol. 26 (6), pp. 485-491.
DOI: 10.5152/AnatolJCardiol.2022.1631
Abstrakt: Background: High-power short-duration radiofrequency ablation has improved lesion durability in pulmonary vein isolation. In this study, we investigate long-term clinical out-comes of high-power short-duration pulmonary vein isolation and posterior wall debulk- ing as an initial treatment modality in all corner atrial fibrillation patients.
Methods: This is a single-center, retrospective, observational study including all patients who have undergone high-power short-duration pulmonary vein and posterior wall deb-ulking, regardless of atrial fibrillation type and/or duration. High-power short-duration power delivery protocol was defined as 45 W at all ablation sites. Clinical and electrocar-diographic follow-up were performed in all patients.
Results: One hundred forty-two patients were enrolled in this study. Paroxysmal atrial fibrillation was present in 88 (62%) of patients. The mean follow-up of this study was 36.9 months ± 12.2 months. During the follow-up period, 10 patients (11.4%) with a diag- nosis of paroxysmal atrial fibrillation had recurrence, while recurrence in patients with persistent and long-standing persistent atrial fibrillation was slightly higher (15 patients (28.1%) and 5 patients (50%), respectively). No major life-threatening complicationsoccurred.
Conclusion: This study has demonstrated excellent arrhythmia-free outcomes in unselected, real world atrial fibrillation patients undergoing high-power short-duration pulmonary vein and debulking posterior wall isolations, however larger randomized trials are warranted.
Databáze: MEDLINE
Externí odkaz: